tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

JD Health International to Announce 2024 Annual Results and Consider Dividend

Story Highlights
JD Health International to Announce 2024 Annual Results and Consider Dividend

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from JD Health International, Inc. ( (HK:6618) ) is now available.

JD Health International Inc. has announced that its Board of Directors will meet on March 6, 2025, to approve and publish the annual financial results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend payment. A conference call is scheduled on the same day to discuss the financial results, which suggests an effort to maintain transparent communication with its stakeholders and could impact investor confidence and stock market positioning.

More about JD Health International, Inc.

JD Health International Inc. is a company incorporated in the Cayman Islands with limited liability, focusing on health-related services and products. It operates within the healthcare industry, providing a range of health management solutions and pharmaceutical products, primarily in the Chinese market.

YTD Price Performance: 25.44%

Average Trading Volume: 11,680,196

Technical Sentiment Consensus Rating: Sell

Current Market Cap: HK$114.3B

For detailed information about 6618 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1